| Year |
Citation |
Score |
| 2019 |
Manwell LA, Miladinovic T, Raaphorst E, Rana S, Malecki S, Mallet PE. Chronic nicotine exposure attenuates the effects of Δ -tetrahydrocannabinol on anxiety-related behavior and social interaction in adult male and female rats. Brain and Behavior. e01375. PMID 31583843 DOI: 10.1002/Brb3.1375 |
0.472 |
|
| 2015 |
Manwell LA, Mallet PE. Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats. Psychopharmacology. 232: 1655-65. PMID 25395060 DOI: 10.1007/s00213-014-3798-5 |
0.313 |
|
| 2014 |
Manwell LA, Ford B, Matthews BA, Heipel H, Mallet PE. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part II: comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents. Journal of Pharmacological and Toxicological Methods. 70: 112-9. PMID 24956154 DOI: 10.1016/J.Vascn.2014.06.004 |
0.453 |
|
| 2012 |
Perit KE, Gmaz JM, Caleb Browne JD, Matthews BA, Dunn MB, Yang L, Raaphorst T, Mallet PE, McKay BE. Distribution of c-Fos immunoreactivity in the rat brain following abuse-like toluene vapor inhalation. Neurotoxicology and Teratology. 34: 37-46. PMID 22074881 DOI: 10.1016/J.Ntt.2011.10.007 |
0.739 |
|
| 2010 |
Hanstock TL, Mallet PE, Clayton EH. Increased plasma d-lactic acid associated with impaired memory in rats. Physiology & Behavior. 101: 653-9. PMID 20888356 DOI: 10.1016/j.physbeh.2010.09.018 |
0.687 |
|
| 2010 |
Rana SA, Mallet PE, Robertson BA, Wainwright PE. Effect of complete maternal and littermate deprivation on morphine-induced Fos-immunoreactivity in the adult male rat brain. Pediatric Research. 67: 263-7. PMID 19915516 DOI: 10.1203/Pdr.0B013E3181Ca0807 |
0.599 |
|
| 2009 |
Verty AN, Boon WM, Mallet PE, McGregor IS, Oldfield BJ. Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716). The European Journal of Neuroscience. 29: 2207-16. PMID 19490094 DOI: 10.1111/j.1460-9568.2009.06750.x |
0.772 |
|
| 2009 |
Mallet PE, Moore CA, Collie MT, Satvat E. Regional distribution of Ginkgo biloba-induced c-Fos immunoreactivity. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 16: 361-8. PMID 18757190 DOI: 10.1016/J.Phymed.2008.07.007 |
0.798 |
|
| 2009 |
Satvat E, Mallet PE. Chronic administration of a Ginkgo biloba leaf extract facilitates acquisition but not performance of a working memory task. Psychopharmacology. 202: 173-85. PMID 18594796 DOI: 10.1007/S00213-008-1223-7 |
0.771 |
|
| 2008 |
Quinn HR, Matsumoto I, Callaghan PD, Long LE, Arnold JC, Gunasekaran N, Thompson MR, Dawson B, Mallet PE, Kashem MA, Matsuda-Matsumoto H, Iwazaki T, McGregor IS. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1113-26. PMID 17581536 DOI: 10.1038/sj.npp.1301475 |
0.509 |
|
| 2006 |
O'Shea M, McGregor IS, Mallet PE. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. Journal of Psychopharmacology (Oxford, England). 20: 611-21. PMID 16714325 DOI: 10.1177/0269881106065188 |
0.658 |
|
| 2006 |
Gardner A, Mallet PE. Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor 'silent antagonist'. European Journal of Pharmacology. 530: 103-6. PMID 16380113 DOI: 10.1016/J.Ejphar.2005.11.032 |
0.454 |
|
| 2006 |
Singh ME, McGregor IS, Mallet PE. Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 58-69. PMID 15920503 DOI: 10.1038/Sj.Npp.1300770 |
0.82 |
|
| 2005 |
Young JM, McGregor IS, Mallet PE. Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1475-82. PMID 16178074 DOI: 10.1038/Sj.Npp.1300692 |
0.648 |
|
| 2005 |
O'Shea M, Mallet PE. Impaired learning in adulthood following neonatal delta9-THC exposure. Behavioural Pharmacology. 16: 455-61. PMID 16148451 DOI: 10.1097/00008877-200509000-00019 |
0.559 |
|
| 2005 |
Singh ME, McGregor IS, Mallet PE. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity. Neuropharmacology. 49: 1189-200. PMID 16137723 DOI: 10.1016/J.Neuropharm.2005.07.008 |
0.822 |
|
| 2005 |
Verty AN, McGregor IS, Mallet PE. Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacology. 49: 1101-9. PMID 16098995 DOI: 10.1016/J.Neuropharm.2005.03.025 |
0.814 |
|
| 2005 |
McGregor IS, Dam KD, Mallet PE, Gallate JE. Delta9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour. Alcohol and Alcoholism (Oxford, Oxfordshire). 40: 35-45. PMID 15550450 DOI: 10.1093/Alcalc/Agh113 |
0.627 |
|
| 2004 |
O'Shea M, Singh ME, McGregor IS, Mallet PE. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. Journal of Psychopharmacology (Oxford, England). 18: 502-8. PMID 15582916 DOI: 10.1177/0269881104047277 |
0.782 |
|
| 2004 |
Singh ME, Verty AN, Price I, McGregor IS, Mallet PE. Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716. Neuropharmacology. 47: 1157-69. PMID 15567425 DOI: 10.1016/J.Neuropharm.2004.08.008 |
0.792 |
|
| 2004 |
Singh ME, Verty AN, McGregor IS, Mallet PE. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Research. 1026: 244-53. PMID 15488486 DOI: 10.1016/J.Brainres.2004.08.027 |
0.786 |
|
| 2004 |
Verty AN, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake. Neuropharmacology. 47: 593-603. PMID 15380376 DOI: 10.1016/J.Neuropharm.2004.06.002 |
0.795 |
|
| 2004 |
Verty AN, McGregor IS, Mallet PE. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol. Brain Research. 1020: 188-95. PMID 15312802 DOI: 10.1016/J.Brainres.2004.06.033 |
0.81 |
|
| 2004 |
Hanstock TL, Clayton EH, Li KM, Mallet PE. Anxiety and aggression associated with the fermentation of carbohydrates in the hindgut of rats. Physiology & Behavior. 82: 357-68. PMID 15276799 DOI: 10.1016/J.Physbeh.2004.04.002 |
0.731 |
|
| 2004 |
Morley KC, Li KM, Hunt GE, Mallet PE, McGregor IS. Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats. Neuropharmacology. 46: 954-65. PMID 15081792 DOI: 10.1016/J.Neuropharm.2004.01.002 |
0.569 |
|
| 2004 |
Verty AN, McFarlane JR, McGregor IS, Mallet PE. Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology. 145: 3224-31. PMID 15033920 DOI: 10.1210/En.2004-0059 |
0.801 |
|
| 2004 |
Verty AN, McGregor IS, Mallet PE. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neuroscience Letters. 354: 217-20. PMID 14700735 DOI: 10.1016/J.Neulet.2003.10.035 |
0.79 |
|
| 2004 |
Gallate JE, Mallet PE, McGregor IS. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Psychopharmacology. 173: 210-6. PMID 14663553 DOI: 10.1007/S00213-003-1694-5 |
0.596 |
|
| 2003 |
Verty AN, Singh ME, McGregor IS, Mallet PE. The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. Psychopharmacology. 168: 314-23. PMID 12700881 DOI: 10.1007/S00213-003-1451-9 |
0.79 |
|
| 2003 |
Norwood CS, Cornish JL, Mallet PE, McGregor IS. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. European Journal of Pharmacology. 465: 105-14. PMID 12650839 DOI: 10.1016/S0014-2999(03)01455-9 |
0.642 |
|
| 2003 |
Allen KV, McGregor IS, Hunt GE, Singh ME, Mallet PE. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain. Neuropharmacology. 44: 264-74. PMID 12623225 DOI: 10.1016/S0028-3908(02)00364-7 |
0.821 |
|
| 2001 |
Morley KC, Gallate JE, Hunt GE, Mallet PE, McGregor IS. Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). European Journal of Pharmacology. 433: 91-9. PMID 11755138 DOI: 10.1016/S0014-2999(01)01512-6 |
0.603 |
|
| 2001 |
Arnold JC, Topple AN, Mallet PE, Hunt GE, McGregor IS. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain. Brain Research. 921: 240-55. PMID 11720732 DOI: 10.1016/S0006-8993(01)03127-4 |
0.633 |
|
| 1999 |
Gallate JE, Saharov T, Mallet PE, McGregor IS. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. European Journal of Pharmacology. 370: 233-40. PMID 10334497 DOI: 10.1016/S0014-2999(99)00170-3 |
0.62 |
|
| 1999 |
Mason KI, Mallet PE, Jhamandas K, Boegman RJ, Beninger RJ. Nucleus basalis injections of N-methyl-D-aspartate enhance memory of rats in the double Y-maze. Brain Research Bulletin. 48: 65-71. PMID 10210169 DOI: 10.1016/S0361-9230(98)00146-4 |
0.606 |
|
| 1998 |
Mallet PE, Beninger RJ. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology. 140: 11-9. PMID 9862397 DOI: 10.1007/S002130050733 |
0.602 |
|
| 1998 |
Mallet PE, Beninger RJ. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance. Life Sciences. 62: 2431-9. PMID 9651110 DOI: 10.1016/S0024-3205(98)00226-4 |
0.623 |
|
| 1998 |
Abrahams BS, Rutherford JD, Mallet PE, Beninger RJ. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434. European Journal of Pharmacology. 343: 111-8. PMID 9570457 DOI: 10.1016/S0014-2999(97)01531-8 |
0.62 |
|
| 1996 |
Mallet PE, Beninger RJ. The endogenous cannabinoid receptor agonist anandamide impairs memory in rats Behavioural Pharmacology. 7: 276-284. DOI: 10.1097/00008877-199605000-00008 |
0.627 |
|
| 1995 |
Mallet PE, Beninger RJ, Flesher SN, Jhamandas K, Boegman RJ. Nucleus basalis lesions: implication of basoamygdaloid cholinergic pathways in memory. Brain Research Bulletin. 36: 51-6. PMID 7882049 DOI: 10.1016/0361-9230(94)00162-T |
0.559 |
|
| 1995 |
Beninger RJ, Wirsching BA, Mallet PE, Jhamandas K, Boegman RJ. Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats. Pharmacology, Biochemistry, and Behavior. 51: 739-46. PMID 7675853 DOI: 10.1016/0091-3057(95)00024-Q |
0.579 |
|
| 1994 |
Smith CG, Beninger RJ, Mallet PE, Jhamandas K, Boegman RJ. Basal forebrain injections of the benzodiazepine partial inverse agonist FG 7142 enhance memory of rats in the double Y-maze. Brain Research. 666: 61-7. PMID 7889368 DOI: 10.1016/0006-8993(94)90282-8 |
0.627 |
|
| 1994 |
Mallet PE, Beninger RJ. 7-OH-DPAT produces place conditioning in rats. European Journal of Pharmacology. 261: R5-6. PMID 7813542 DOI: 10.1016/0014-2999(94)90127-9 |
0.631 |
|
| Show low-probability matches. |
